BMC Cancer

Table 4 Outcomes by response measurement

From: Locally advanced breast cancer treated with neoadjuvant chemotherapy and adjuvant radiotherapy: a retrospective cohort analysis

		LRC			RFS			OS
		1 year (%)	5 years (%)	p-value	1 year (%)	5 years (%)	p-value	1 year (%)	5 years (%)	p-value
Standard pathology				0.48			*0.015*			*0.015*
	pCR	100	92		100	92		100	100
	PR	100	88		98	63		100	71
	NR	94	84		86	43		100	65
Chevallier
	1 (pCR)	100	86	0.96	100	86	*0.06*	100	100	*0.005*
	2	100	91		100	91		100	100
	3	100	90		97	58		100	70
	4	100	N/A		89	N/A		100	N/A
Modified-RECIST
	5 (pCR)	100	94	0.45	100	94	*0.003*	100	100	*0.011*
	3 + 4	100	87		98	60		100	71
	1 + 2	93	86		87	40		100	57

Abbreviations: LRC locoregional control rate, NR no response, OS overall survival, pCR pathologic complete response, PR partial response, RECIST Response Evaluation Criteria in Solid Tumors, RFS recurrence-free survival

Back to article page

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com